GetTopicDetailResponse(id=a0a816469b0, topicName=SMYD3, introduction=SMYD3, content=null, image=null, comments=1, allHits=1597, url=https://h5.medsci.cn/topic?id=16469, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=16522, tagList=[TagDto(tagId=16522, tagName=SMYD3)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2253334, encodeId=abcc22533345a, content=<a href='/topic/show?id=3f091003426' target=_blank style='color:#2F92EE;'>#IRF3#</a> <a href='/topic/show?id=a0a816469b0' target=_blank style='color:#2F92EE;'>#SMYD3#</a> <a href='/topic/show?id=d1c1124551a1' target=_blank style='color:#2F92EE;'>#二甲基化#</a>, objectTitle=PNAS：中國科學院肖武漢課題組發(fā)現(xiàn)蛋白SMYD3抑制抗病毒免疫反應(yīng), objectType=article, longId=864378, objectId=a8e08643e802, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/bioon-com/20250222/1740221881143_2185383.png, objectUrl=/article/show_article.do?id=a8e08643e802, replyNumber=0, likeNumber=24, createdTime=2025-02-24, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=0, avatar=, status=0, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=null, followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2224417, encodeId=efbd222441e94, content=<a href='/topic/show?id=73c423e2572' target=_blank style='color:#2F92EE;'>#乳腺癌#</a> <a href='/topic/show?id=a0a816469b0' target=_blank style='color:#2F92EE;'>#SMYD3#</a>, objectTitle=Adv Sci：田春艷/王建/高海東合作發(fā)現(xiàn)ZNF8與Smad3協(xié)調(diào)，通過在乳腺癌中募集SMYD3促進肺轉(zhuǎn)移, objectType=article, longId=841938, objectId=c5148419387c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240905/1725523007505_8538692.jpg, objectUrl=/article/show_article.do?id=c5148419387c, replyNumber=0, likeNumber=93, createdTime=2024-09-06, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=c5148419387c, moduleTitle=Adv Sci：田春艷/王建/高海東合作發(fā)現(xiàn)ZNF8與Smad3協(xié)調(diào)，通過在乳腺癌中募集SMYD3促進肺轉(zhuǎn)移, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=c5148419387c)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1247589, encodeId=9a90124e5899b, content=<a href='/topic/show?id=5e2e4e08988' target=_blank style='color:#2F92EE;'>#小細胞肺癌#</a>這項研究值得后續(xù)進行藥物開發(fā)，包括針對E3泛素化的降解的<a href='/topic/show?id=c6f814e5136' target=_blank style='color:#2F92EE;'>#PROTAC#</a>類藥物開發(fā)，以及針對<a href='/topic/show?id=a0a816469b0' target=_blank style='color:#2F92EE;'>#SMYD3#</a> 和 RNF113A<a href='/topic/show?id=07a69996557' target=_blank style='color:#2F92EE;'>#靶點#</a>的藥物開發(fā)，可能都具有一定的潛力。, objectTitle=Cancer Discov：小細胞肺癌對烷基化藥物的耐藥機制被發(fā)現(xiàn), objectType=article, longId=738457, objectId=803be38457a5, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20220901/397b60e7acfb475f9122c711ceb7558e.jpg, objectUrl=/article/show_article.do?id=803be38457a5, replyNumber=0, likeNumber=211, createdTime=2022-09-07, rootId=0, userName=小小醫(yī)者, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=803be38457a5, moduleTitle=Cancer Discov：小細胞肺癌對烷基化藥物的耐藥機制被發(fā)現(xiàn), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=803be38457a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
